Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial (CALIFORNIA)
Comparison of Unfractionated Heparin and Bivalirudin for Percutaneous Coronary Intervention for Stable Angina, Unstable Angina, and Non-ST Segment Elevation Myocardial Infarction
Sponsor: Kaiser Permanente
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Kaiser Permanente
Other Percutaneous Coronary Intervention trials with similar outcome
A PHASE3 clinical study on Percutaneous Coronary Intervention, this trial is terminated or withdrawn. The trial is conducted by Kaiser Permanente and has accumulated 5 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kaiser Permanente
For direct contact, visit the study record on ClinicalTrials.gov .